Teladoc Health, Inc. (NYSE:TDOC) Given Average Recommendation of “Hold” by Brokerages

Teladoc Health, Inc. (NYSE:TDOC) has received a consensus recommendation of “Hold” from the twenty-one research firms that are presently covering the stock, MarketBeat Ratings reports. Fourteen investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $12.24.

TDOC has been the subject of a number of recent research reports. The Goldman Sachs Group initiated coverage on shares of Teladoc Health in a report on Friday, November 15th. They issued a “buy” rating and a $14.00 price objective for the company. Jefferies Financial Group upped their price objective on shares of Teladoc Health from $8.00 to $10.00 and gave the stock a “hold” rating in a report on Tuesday, September 17th. TD Cowen decreased their price objective on shares of Teladoc Health from $9.00 to $8.00 and set a “hold” rating for the company in a report on Thursday, October 31st. Evercore ISI upped their price objective on shares of Teladoc Health from $8.00 to $9.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on shares of Teladoc Health from $10.00 to $12.00 and gave the company a “hold” rating in a report on Friday, November 1st.

Teladoc Health Trading Down 2.4 %

NYSE TDOC opened at $9.09 on Thursday. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $22.54. The company has a current ratio of 1.73, a quick ratio of 1.69 and a debt-to-equity ratio of 0.66. The company has a market capitalization of $1.56 billion, a PE ratio of -1.58 and a beta of 0.97. The firm’s fifty day simple moving average is $9.85 and its 200-day simple moving average is $9.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.10. The firm had revenue of $640.51 million during the quarter, compared to analysts’ expectations of $630.50 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, sell-side analysts anticipate that Teladoc Health will post -1.16 earnings per share for the current fiscal year.

Insider Activity

In related news, insider Carlos Nueno sold 2,389 shares of the stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $11.93, for a total value of $28,500.77. Following the completion of the transaction, the insider now owns 2,890 shares of the company’s stock, valued at $34,477.70. This represents a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.95% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in TDOC. Rubric Capital Management LP acquired a new position in Teladoc Health in the second quarter worth about $45,267,000. Point72 Asset Management L.P. raised its position in Teladoc Health by 221.9% in the second quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider’s stock worth $51,865,000 after purchasing an additional 3,655,436 shares in the last quarter. Clearline Capital LP raised its position in Teladoc Health by 395.6% in the second quarter. Clearline Capital LP now owns 4,364,201 shares of the health services provider’s stock worth $42,682,000 after purchasing an additional 3,483,665 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in Teladoc Health in the third quarter worth about $15,801,000. Finally, Maple Rock Capital Partners Inc. acquired a new stake in shares of Teladoc Health during the third quarter worth approximately $11,291,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.